CRIM1 is expressed at higher levels in drug-resistant than in drug-sensitive myeloid leukemia HL60 cells.
Prenkert
Malin
M
School of Health and Medical Sciences, Orebro University Hospital, Orebro, Sweden. malin.prenkert@orebroll.se
Uggla
Bertil
B
Tidefelt
Ulf
U
Strid
Hilja
H
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000096:biosynthesis / Q000235:genetics; D055415:Bone Morphogenetic Protein 4 / Q000096:biosynthesis / Q000235:genetics; D055419:Bone Morphogenetic Protein 7 / Q000096:biosynthesis / Q000235:genetics; D052004:Bone Morphogenetic Protein Receptors; D003561:Cytarabine / Q000494:pharmacology; D003630:Daunorubicin / Q000494:pharmacology; D018432:Drug Resistance, Multiple; D019008:Drug Resistance, Neoplasm; D005455:Fluorescent Antibody Technique; D018922:HL-60 Cells; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism*; D008565:Membrane Proteins / Q000096:biosynthesis* / Q000235:genetics; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D051902:Smad5 Protein / Q000096:biosynthesis / Q000235:genetics
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; C525809:BMP4 protein, human; C525819:BMP7 protein, human; D055415:Bone Morphogenetic Protein 4; D055419:Bone Morphogenetic Protein 7; C486175:CRIM1 protein, human; D008565:Membrane Proteins; D012333:RNA, Messenger; C497797:SMAD5 protein, human; D051902:Smad5 Protein; D003561:Cytarabine; D052004:Bone Morphogenetic Protein Receptors; D003630:Daunorubicin